Atrial Fibrillation Decision Support Tool: Population Perspective
Conclusions Availability of DOACs increases the proportion of patients for whom oral anticoagulation therapy is recommended in a real-world cohort of AF patients and increased projected QALYs by more than 1500 when all patients are receiving thromboprophylaxis as recommended by the AFDST compared with current treatment.
Source: American Heart Journal - Category: Cardiology Source Type: research
More News: Academia | Aspirin | Atrial Fibrillation | Bleeding | Cardiology | Coumadin | Heart | Stroke | Study | USA Health | Warfarin